These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Predictors of antimalarial treatment failure in an area of unstable malaria transmission in eastern Sudan. Adam I, Elmardi KA, Malik EM. Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):21-4. PubMed ID: 18718621 [Abstract] [Full Text] [Related]
23. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Geerligs PD, Brabin BJ, Eggelte TA. Bull World Health Organ; 2003 Jan; 81(3):205-16. PubMed ID: 12764517 [Abstract] [Full Text] [Related]
24. The prevalence of Plasmodia parasitaemia among donors in the Niger delta of Nigeria. Erhabor O, Ok O, Awah I, Uko KE, Charles AT. Trop Doct; 2007 Jan; 37(1):32-4. PubMed ID: 17326885 [Abstract] [Full Text] [Related]
25. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J. Clin Infect Dis; 2007 Jul 01; 45(1):16-25. PubMed ID: 17554695 [Abstract] [Full Text] [Related]
26. C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with plasmodium falciparum. Arinola G, Ezeh C. Iran J Immunol; 2007 Mar 01; 4(1):44-9. PubMed ID: 17652843 [Abstract] [Full Text] [Related]
27. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC. Clin Infect Dis; 2009 Sep 15; 49(6):841-9. PubMed ID: 19673614 [Abstract] [Full Text] [Related]
28. A comparison of the prevalence of malaria parasitaemia in pregnant and non pregnant women. Nnaji GA, Ikechebelu JI, Okafor CI. Niger J Med; 2009 Sep 15; 18(1):47-51. PubMed ID: 19485148 [Abstract] [Full Text] [Related]
29. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. Tukur IU, Thacher TD, Sagay AS, Madaki JK. Am J Trop Med Hyg; 2007 Jun 15; 76(6):1019-23. PubMed ID: 17556604 [Abstract] [Full Text] [Related]
30. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria. Ogunfowokan O, Dankyau M, Madaki AJ, Thacher TD. Am J Trop Med Hyg; 2009 Feb 15; 80(2):199-201. PubMed ID: 19190213 [Abstract] [Full Text] [Related]
35. Malaria specific-IgG, inter-pregnancy intervals, birth weights and body mass index in cases of asymptomatic malaria parasitaemia. Onyenekwe CC, Arinola OG, Meludu SC, Salimonu LS, Obisesan AK, Adewale IF. J Vector Borne Dis; 2004 Feb 15; 41(1-2):1-4. PubMed ID: 15332479 [Abstract] [Full Text] [Related]
36. Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study. Eke FU, Anochie I. Curr Ther Res Clin Exp; 2003 Sep 15; 64(8):616-25. PubMed ID: 24944408 [Abstract] [Full Text] [Related]